Panel Discussion: Defining Clinical Endpoints for Rare Diseases

Time: 2:00 pm
day: Day Two

Details:

  • Incorporating patient perspectives to define a suitable primary endpoint
  • Assessing measurability as a factor in endpoint choice
  • Navigating challenges of clinical trial design with a small patient population

Speakers: